Dr. Prasun Mishra is a leading life science, technology, and healthcare thought leader and an Impact Investor. A scientist with numerous publications/ patents to his credit. He has contributed to developing several drugs and combinations in trials and approved and has over 40 prestigious awards and over 35 keynote talks & invited lectureships. During his distinguished career, he served the pharma giant Genentech, Roche, Rutgers University and NCI, NIH, DHHS, U.S. Government. He is a Founding Partner of GSIF: Global Sustainability Impact Fund LLC.
Dr. Mishra is also a founding partner in the Silicon Valley-based M7 Healthcare Accelerator (now renamed H7). He is a co-founder of Precision BioPharma Inc. and Agility Pharmaceuticals. Among his professional associations, he serves American Association for Precision Medicine (AAPM) as the founding president. Dr. Mishra, an impact investor, is also the Founding Chair of WISE: World Investors and Entrepreneurs Society, an investment collective with a global footprint. He is also a part of a few angel groups. Dr. Mishra is an advisor to a few venture capital and private equity firms, including Barcelona Ventures, Legacy Health Capital, Elysium Ventures, and Global Health Impact Fund. He also currently serves as a member of the Board of Directors at the University of California San Francisco (UCSF) Health Hub and is an advisor to UCSF's Catalyst Program, Innovation Ventures, and InVent Fund. He led research efforts focused on preventing & curing chronic diseases, not only treating the sick but also providing knowledge/ tools to individuals to live longer, healthier lives. Due to his unique perspective and selfless service, he is a highly respected and sought-after mentor to many.
